Canada Markets closed

Repro Med Systems, Inc. (KRMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.1600+0.0600 (+2.86%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close2.1000
Open2.0500
Bid1.0000 x 1000
Ask3.0000 x 1100
Day's Range2.0000 - 2.1900
52 Week Range1.9000 - 4.8300
Volume123,532
Avg. Volume42,504
Market Cap96.252M
Beta (5Y Monthly)0.31
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    KORU Medical Systems Announces 2022 First Quarter Financial Results

    CHESTER, N.Y., May 04, 2022--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today reported financial results for the first quarter ended March 31, 2022.

  • Business Wire

    KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label for FreedomEdge®

    CHESTER, N.Y., May 02, 2022--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced 510k clearance for use of the KORU Medical FreedomEdge® infusion system to deliver pegcetacoplan 20 mL solution, branded as EMPAVELI® or Aspaveli® and c

  • Business Wire

    KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022

    CHESTER, N.Y., April 20, 2022--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the Company will report first quarter 2022 financial results on Wednesday, May 4, 2022. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corp